Cargando…
PARACOCCIDIOIDOMYCOSIS: CHALLENGES IN THE DEVELOPMENT OF A VACCINE AGAINST AN ENDEMIC MYCOSIS IN THE AMERICAS
Paracoccidioidomycosis (PCM), caused by Paracoccidioides spp, is an important endemic mycosis in Latin America. There are two recognized Paracoccidioides species, P. brasiliensis and P. lutzii, based on phylogenetic differences; however, the pathogenesis and disease manifestations of both are indist...
Autores principales: | TABORDA, Carlos. P., URÁN, M.E., NOSANCHUK, J. D., TRAVASSOS, L.R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto de Medicina Tropical
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711196/ https://www.ncbi.nlm.nih.gov/pubmed/26465365 http://dx.doi.org/10.1590/S0036-46652015000700005 |
Ejemplares similares
-
New advances in the development of a vaccine against paracoccidioidomycosis
por: Travassos, Luiz R., et al.
Publicado: (2012) -
Therapeutic DNA Vaccine Encoding Peptide P10 against Experimental Paracoccidioidomycosis
por: Rittner, Glauce M. G., et al.
Publicado: (2012) -
Neutrophil Cells Are Essential for The Efficacy of a Therapeutic Vaccine against Paracoccidioidomycosis
por: Dias, Lucas dos Santos, et al.
Publicado: (2021) -
Biodistribution and Adjuvant Effect of an Intranasal Vaccine Based on Chitosan Nanoparticles against Paracoccidioidomycosis
por: Santos Júnior, Samuel Rodrigues Dos, et al.
Publicado: (2023) -
Experimental Therapy of Paracoccidioidomycosis Using P10-Primed Monocyte-Derived Dendritic Cells Isolated From Infected Mice
por: Silva, Leandro B. R., et al.
Publicado: (2019)